scaRNA1 levels alter pseudouridylation in spliceosomal RNA U2 affecting alternative mRNA splicing and embryonic development
CK Nagasawa, N Kibiryeva, J Marshall, JE O'Brien… - Pediatric …, 2020 - Springer
The heart is the first major organ to develop during embryogenesis and must receive proper
spatiotemporal signaling for proper development. Failure of proper signaling between the …
spatiotemporal signaling for proper development. Failure of proper signaling between the …
[PDF][PDF] RBFOX2 is critical for maintaining alternative polyadenylation patterns and mitochondrial health in rat myoblasts
…, E Jaworski, S Mohan, CK Nagasawa, K Rayavara… - Cell reports, 2021 - cell.com
RBFOX2, which has a well-established role in alternative splicing, is linked to heart diseases.
However, it is unclear whether RBFOX2 has other roles in RNA processing that can …
However, it is unclear whether RBFOX2 has other roles in RNA processing that can …
Inefficient recruitment of DDX39B impedes pre-spliceosome assembly on FOXP3 introns
CK Nagasawa, AO Bailey, W Russell… - RNA, 2024 - rnajournal.cshlp.org
Forkhead box P3 (FOXP3) is the master fate-determining transcription factor in regulatory T (Treg)
cells and is essential for their development, function and homeostasis. Mutations in …
cells and is essential for their development, function and homeostasis. Mutations in …
[HTML][HTML] Early Splicing Complexes and Human Disease
CK Nagasawa, MA Garcia-Blanco - International Journal of Molecular …, 2023 - mdpi.com
Over the last decade, our understanding of spliceosome structure and function has significantly
improved, refining the study of the impact of dysregulated splicing on human disease. As …
improved, refining the study of the impact of dysregulated splicing on human disease. As …
[HTML][HTML] The role of scaRNAs in adjusting alternative mRNA splicing in heart development
C Nagasawa, A Ogren, N Kibiryeva, J Marshall… - Journal of …, 2018 - mdpi.com
Congenital heart disease (CHD) is a leading cause of death in children <1 year of age.
Despite intense effort in the last 10 years, most CHDs (~70%) still have an unknown etiology. …
Despite intense effort in the last 10 years, most CHDs (~70%) still have an unknown etiology. …
The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate
M Hirano, G Galarza-Muñoz, C Nagasawa, G Schott… - Elife, 2023 - elifesciences.org
Genes associated with increased susceptibility to multiple sclerosis (MS) have been identified,
but their functions are incompletely understood. One of these genes codes for the RNA …
but their functions are incompletely understood. One of these genes codes for the RNA …
The Landscape of C. elegans 3′UTRs
Three-prime untranslated regions (3′UTRs) of metazoan messenger RNAs (mRNAs) contain
numerous regulatory elements, yet remain largely uncharacterized. Using polyA capture, 3…
numerous regulatory elements, yet remain largely uncharacterized. Using polyA capture, 3…
Richemont as focused luxury conglomerate
S TERASAKI, S NAGASAWA - International Journal of Affective …, 2014 - jstage.jst.go.jp
This paper clarifies the competitive advantage of Richemont in comparison to LVMH
particularly from the angle of portfolio strategy. Unlike LVMH, limited numbers of people know …
particularly from the angle of portfolio strategy. Unlike LVMH, limited numbers of people know …
Long-term Exposure to Particulate Matter and Cardiovascular Mortality in a Representative Japanese Cohort: NIPPON DATA80
K Ueda, S Nagasawa, H Nitta, K Miura… - Epidemiology, 2011 - journals.lww.com
Methods: A total of 7250 participants aged 30 years and older from randomly selected 232
census areas, both rural and urban, throughout Japan were followed from 1980 to 2004. We …
census areas, both rural and urban, throughout Japan were followed from 1980 to 2004. We …
[PDF][PDF] Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells
…, A Montel-Hagen, HC Chen, S Lopez, O Zhou, K Dai… - Cell reports, 2023 - cell.com
Generation of chimeric antigen receptor (CAR) T cells from pluripotent stem cells (PSCs)
will enable advances in cancer immunotherapy. Understanding how CARs affect T cell …
will enable advances in cancer immunotherapy. Understanding how CARs affect T cell …